Orchid Can't Nix Roche Boniva Patent

Loeb & Loeb LLP's Mark Waddell and Paula Colbath are noted as counsel for Hoffmann-La Roche Inc. in the pharmaceutical company's infringement actions against Orchid Chemicals & Pharmaceuticals Ltd. over Orchid's proposed generic version of the branded osteoporosis drug Boniva^®. A federal judge rejected Orchid's bid to toss one of the five Boniva^® patents asserted by Roche to prevent Orchid from marketing the generic drug.